Navigation Links
Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
Date:10/27/2011

IRVINE, Calif., Oct. 27, 2011 /PRNewswire/ -- GZP is announcing expansion of its client oncology programs, from strategic and regulatory consulting through product development and clinical trial execution, of pharmaceutical and biological therapies.  These include treatment vaccines, somatic cell and gene therapies, and novel small molecules.  Senior associates with oncology expertise in nonclinical, manufacturing, and clinical development provide clients with hands-on guidance throughout the FDA regulatory review process.  Firms in the US, Europe and Australia are actively working with GZP, in Phase 1 through Phase 3 clinical trials.

Dr. Evan B. Siegel, GZP's CEO, will be at BioEurope in Dusseldorf and BioMalaysia in Kuala Lumpur, and will be pleased to meet with interested parties during either meeting's formal partnering or by individual arrangement.

In 2011, GZP increased its global client base at all development phases across therapeutic areas such as oncology and neurological disease.  The firm created and submitted several INDs and SPAs and facilitated many pre-IND and mid-phase meetings with the FDA leading to rapid movement of client programs.  GZP believes that early, frequent, and creative FDA communication leads to more successful product development and attracts investors in today's difficult financial climate.

According to Evan Siegel, "We are pleased that the disappointing recovery from the global financial crisis has not diminished the entry of new intellectual property into the biotechnology and pharmaceutical space.  Our clients are determined to be successful and we are honored to provide support towards that end.  The expansion of our business is attributable to their trust in GZP, due to the excellence of our team which maintains an integrated and client-specific approach to deliver the highest quality services."

Based in Irvine, Ground Zero Pharmaceuticals, Inc. is a regulatory
'/>"/>

SOURCE Ground Zero Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event
2. Rottenstein Law Group Heeds Groundswell of Grievances Against Manufacturers of Defective, Dangerous Hip Replacement Devices
3. Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
4. Groundbreaking Report Details the New $80 Billion Accountable-Care Market
5. International Dyslexia Association Announces Groundbreaking Parent Membership Initiative in Response to 40,000 Annual Inquiries
6. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
7. Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System
8. SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe
9. Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwCs Medical Technology Innovation Scorecard
10. Groundbreaking Study Showed Bayers Advantage MultiĀ® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
11. Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... , April 26 e-MDs, an industry leader ... and practice management (PM) solutions, announced they have been selected ... Alaska EHR Alliance (AEHRA).   e-MDs was identified through ... Alaska healthcare providers looking to incorporate an EHR in ...
... 26 Sirion Therapeutics, Inc., a privately held ophthalmic ... is now commercially available.  Zirgan™, which was approved by the ... is a topical ophthalmic antiviral indicated for the treatment of ... , , ...
Cached Medicine Technology:Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 2Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 3Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 4Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3
(Date:7/10/2014)... as tempting as full-fat equivalents could be heading ... how proteins can replace fats without affecting foodstuffs, ... Engineering and Physical Sciences Research Council (EPSRC), a ... Edinburgh has produced modified proteins that easily break ... behaviour of fats during food manufacture. The proteins ...
(Date:7/9/2014)... 2014 -- The World Health Organization recommends that youth ... to vigorous physical activity (MVPA) each day. Studies ... during school hours. Therefore, it stands to reason ... MVPA. In a new study scheduled for publication ... that time spent outdoors after school was positively associated ...
(Date:7/9/2014)... Perelman School of Medicine at the University of Pennsylvania ... received an $8 million grant from the National Cancer ... therapy (PDT) in patients with malignant pleural mesothelioma, a ... itself in the lining of the lungs and is ... will fund a clinical trial and additional studies looking ...
(Date:7/9/2014)... Studying the most common type of lung cancer, researchers ... a role in forming tumors. The new knowledge may ... these genetic changes already are available or are in ... , investigators from The Cancer Genome Atlas (TCGA), including ... Louis, Harvard Medical School and other institutions, studied tumors ...
(Date:7/9/2014)... used in policing injection drug users in Russia ... , A study, conducted by researchers from ... in collaboration with St. Petersburg Pavlov State University, ... on the health outcomes of a cohort of ... , Those who were arrested by police were ...
Breaking Medicine News(10 mins):Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2
... triples risk of disease, study funds , , WEDNESDAY, ... to be predictors of esophageal cancer have been identified ... M. D. Anderson Cancer Center team pinpointed 11 single-nucleotide ... with esophageal cancer. , Each of these unfavorable genotypes ...
... Marketing Messages for Advair,and Xolair, According to a ... Nov. 5 Decision Resources one of the,world,s ... and,healthcare issues, finds that physicians and patients respond ... to use.,Physicians indicate that brands conveying messages of ...
... Stay Balanced Through the ... ... and New York Times best-selling author Ellie Krieger, of Food Network,fame, ... health. Yo-Plus contains live and active probiotic cultures,specifically designed for digestive ...
... PITTSBURGH, Nov. 5 CardiacAssist, Inc. announced that,it reached a ... System,performing at least one TandemHeart case during the third quarter ... highest year on,year growth in case activity with a leap ... 70 % and 497 %. Through nine months of 2008,CardiacAssist ...
... for passengers taking 7- to ... 9-hour flights, ... Minerva Cardioangiologica reveals Pycnogenol(R), pine bark,extract from the French maritime pine tree, ... a brain CT scan and a,scoring system, showed Pycnogenol(R) lowered symptoms of ...
... companies is often dependent on their ability to do deals ... A Comprehensive Assessment of Valuation in the Pharmaceutical Sector, the ... aspects of deal-making, including valuations and royalty rate calculations. ... ...
Cached Medicine News:Health News:Researchers ID Genetic Markers for Esophageal Cancer 2Health News:Physicians Rank Schering-Plough's Marketing Messages for Asmanex as the Most Appealing in the Asthma Drug Market 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 3Health News:CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results 2Health News:Study Shows Pine Bark Reduces Jetlag 2Health News:Study Shows Pine Bark Reduces Jetlag 3Health News:Study Shows Pine Bark Reduces Jetlag 4Health News:Determining Valuations in Challenging Times 2Health News:Determining Valuations in Challenging Times 3Health News:Determining Valuations in Challenging Times 4
VG1 ALIF (Anterior Lateral) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Medicine Products: